Deutsche Bank
ALDX icon

Deutsche Bank’s Aldeyra Therapeutics ALDX Stock Holding History

Deutsche Bank’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85K Sell
50,271
-267,064
-84% -$1.17M ﹤0.01% 3331
2025
Q4 		$1.64M Buy
317,335
+2,607
+0.8% +$13.4K ﹤0.01% 1906
2025
Q3 		$1.64M Buy
314,728
+7,953
+3% +$41.5K ﹤0.01% 1889
2025
Q2 		$1.17M Sell
306,775
-7,648
-2% -$19.8K ﹤0.01% 1997
2025
Q1 		$1.81M Sell
314,423
-4,864
-2% -$28.8K ﹤0.01% 1821
2024
Q4 		$1.59M Buy
319,287
+18,696
+6% +$95.9K ﹤0.01% 1984
2024
Q3 		$1.62M Buy
300,591
+239
+0.1% +$1.14K ﹤0.01% 1882
2024
Q2 		$994K Buy
300,352
+7,965
+3% +$31.2K ﹤0.01% 1991
2024
Q1 		$956K Sell
292,387
-5,049
-2% -$16.6K ﹤0.01% 2043
2023
Q4 		$1.04M Buy
297,436
+2,661
+0.9% +$8.21K ﹤0.01% 2001
2023
Q3 		$1.97M Buy
294,775
+6,470
+2% +$48K ﹤0.01% 1364
2023
Q2 		$2.42M Buy
288,305
+64,251
+29% +$633K ﹤0.01% 1536
2023
Q1 		$2.22M Sell
224,054
-5,400
-2% -$38.2K ﹤0.01% 1632
2022
Q4 		$1.6M Hold
229,454
– – ﹤0.01% 1777
2022
Q3 		$1.23M Hold
229,454
– – ﹤0.01% 1854
2022
Q2 		$916K Sell
229,454
-66,373
-22% -$228K ﹤0.01% 2242
2022
Q1 		$1.31M Buy
295,827
+34,851
+13% +$139K ﹤0.01% 2178
2021
Q4 		$1.04M Buy
260,976
+1,552
+0.6% +$11.8K ﹤0.01% 2413
2021
Q3 		$2.28M Sell
259,424
-900
-0.3% -$8.26K ﹤0.01% 1995
2021
Q2 		$2.95M Sell
260,324
-39,309
-13% -$473K ﹤0.01% 1884
2021
Q1 		$3.56M Hold
299,633
– – ﹤0.01% 1772
2020
Q4 		$2.06M Buy
299,633
+119,409
+66% +$838K ﹤0.01% 1941
2020
Q3 		$1.33M Buy
180,224
+100,667
+127% +$650K ﹤0.01% 1991
2020
Q2 		$332K Buy
79,557
+63,100
+383% +$231K ﹤0.01% 2852
2020
Q1 		$40K Sell
16,457
-17,445
-51% -$78.5K ﹤0.01% 3645
2019
Q4 		$195K Buy
33,902
+18,742
+124% +$108K ﹤0.01% 3240
2019
Q3 		$79K Sell
15,160
-11,722
-44% -$63.1K ﹤0.01% 3681
2019
Q2 		$160K Sell
26,882
-8,766
-25% -$66K ﹤0.01% 3950
2019
Q1 		$321K Sell
35,648
-4,010
-10% -$34.1K ﹤0.01% 3719
2018
Q4 		$328K Buy
39,658
+1,279
+3% +$13.1K ﹤0.01% 3590
2018
Q3 		$530K Buy
38,379
+7,823
+26% +$63.5K ﹤0.01% 3750
2018
Q2 		$243K Buy
+30,556
New +$244K ﹤0.01% 4199
2018
Q1 		– Sell
-1,700
Closed -$11K – 5366
2017
Q4 		$11K Sell
1,700
-6,300
-79% -$41.5K ﹤0.01% 4759
2017
Q3 		$57K Buy
+8,000
New +$41.8K ﹤0.01% 4339
2017
Q2 		– Sell
-7,961
Closed -$39K – 4912
2017
Q1 		$39K Buy
+7,961
New +$41K ﹤0.01% 4298
2015
Q3 		– Sell
-29
Closed – – 5177
2015
Q2 		$0 Sell
29
-2,501
-99% -$21.6K ﹤0.01% 5314
2015
Q1 		$25K Buy
+2,530
New +$25.8K ﹤0.01% 4600
2014
Q3 		– Sell
-70
Closed – – 5867
2014
Q2 		$0 Buy
+70
New +$470 ﹤0.01% 5862

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's ALDX Position: Q1 2026 in Review

Deutsche Bank reduced its Aldeyra Therapeutics (ALDX) stake by 84% in Q1 2026, selling an estimated $1.17M and leaving 50,271 shares worth $85K. The position accounts for ﹤0.01% of the portfolio, ranked #3331.

Deutsche Bank first reported a position in ALDX in Q2 2014 and has held it in 38 quarters since. The position peaked at $3.56M in Q1 2021. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Deutsche Bank held 50,271 shares of Aldeyra Therapeutics worth $85K as of Q1 2026.
  • Deutsche Bank sold 267,064 Aldeyra Therapeutics shares in Q1 2026, an estimated $1.17M.
  • Aldeyra Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3331 holding.
  • Deutsche Bank first reported a position in Aldeyra Therapeutics in Q2 2014 and has held it in 38 quarters since.
  • Deutsche Bank's Aldeyra Therapeutics position peaked at $3.56M in Q1 2021.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.